SIGA Technologies, Inc.
SIGAHealthcareNASDAQDrug Manufacturers - Specialty & Generic
Scan Results
Daily timeframePart of the healthcare sector, SIGA Technologies, Inc. (SIGA) is listed under Drug Manufacturers - Specialty & Generic. Valued at $236.4M, SIGA is a micro-cap name in its sector. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus.
Market Cap
$236.4M
Beta
0.89
P/E (TTM)
—
P/E (Fwd)
3.05
EPS (TTM)
$-0.04
EPS (Fwd)
$1.08
ROE
-1.5%
ROA
-3.4%
Cash
$117.6M
Total Debt
$439,397
Free CF
-$24.0M
52W Change
-62.4%
Annual Financials
Cash vs Debt
Where SIGA stands vs its 150-day and 200-day moving averages
As of the August 19, 2026 close, SIGA finished 34.43% below its 150-day moving average ($4.56) and 38.35% below its 200-day moving average ($4.85). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SIGA overbought or oversold?
At the August 19, 2026 close, SIGA's RSI(14) was 28.9, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
SIGA Technologies, Inc. holds $117.6M in cash against $439K in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow is running at -$24.0M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -1.5%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $110.8M (2022) to $94.6M (2025), a 15% decline worth watching.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for SIGA Technologies, Inc. and its sector.